Identification of the novel canine CYP1A2 1117 C>T SNP causing protein deletion

References

• AKLILLU, E., CARRILLO, J. A., MAKONNEN, E., HELLMAN, K., PITARQUE, M., BERTILSSON, L. and INGELMAN-SUNDBERG, M., 2003, Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1. Molecular Pharmacology, 64, 659–669.
   Google Scholar
• ALLORGE, D., CHEVALIER, D., Lo-GumicE, J. M., CAUFFIEZ, C., SUARD, F., BAUMANN, P., EAP, C. B. and BROLY, F., 2003, Identification of a novel splice-site mutation in the CYP1A2 gene. British Journal of Clinical Pharmacology, 56, 341–344.
   Google Scholar
• AZUMA, R., KOMURO, M., KAWAGUCHI, Y., OKUDAIRA, K., HAYASHI, M. and KIWADA, H., 2002, Comparative analysis of in vitro and in vivo pharmacokinetic parameters related to individual variability of GTS-21 in canine. Drug Metabolism Pharmacokinetics, 17, 75–82.
   PubMedGoogle Scholar
• BERTZ, R. J. and GRANNEMAN, G. R., 1997, Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. Clinical Pharmacokinetics, 32, 210–258.
   PubMed Web of Science ®Google Scholar
• BLAISDELL, J., GOLDSTEIN, J. A. and BAI, S. A., 1998, Isolation of a new canine cytochrome P450 cDNA from the cytochrome P450 2C subfamily (CYP2C41) and evidence for polymorphic differences in its expression. Drug Metabolism and Disposition, 26, 278–283.
   PubMed Web of Science ®Google Scholar
• CIACCIO, P. J., GRAVES, P. E., BOURQUE, D. P., GLINSMANN-GIBSON, B. and HALPERT, J. R., 1991, cDNA and deduced amino acid sequences of a dog liver cytochrome P-450 of the IIIA gene subfamily. Biochimica et Biophysica Acta, 1088, 319–322.
   Google Scholar
• COLEMAN, T., ELLIS, S. W., MARTIN, I. J., LENNARD, M. S. and TUCKER, G. T., 1996, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4 - implications for susceptibility to Parkinson's disease. Journal of Pharmacology and Experimental Therapeutics, 277, 685–690.
   PubMed Web of Science ®Google Scholar
• FRASER, D. J., FEYEREISEN, R., HARLOW, G. R. and HALPERT, J. R., 1997, Isolation, heterologous expression and functional characterization of a novel cytochrome P450 3A enzyme from a canine liver cDNA library. Journal of Pharmacology and Experimental Therapeutics, 283, 1425–1432.
   PubMed Web of Science ®Google Scholar
• FURUTA, T., OHASHI, K., KOSUGE, K., ZHAO, X. J., TAKASHIMA, M., KIMURA, M., NISHIMOTO, M., HANAI, H., KANEKO, E. and IsHiz.ARI, T., 1999, CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans. Clinical Pharmacology and Therapeutics, 65, 552–561.
   Google Scholar
• GOODERHAM, N. J., MURRAY, S., LYNCH, A. M., EDWARDS, R. J., YADOLLAHI-FARSANI, M., BRATT, C., RICH, K. J., ZHAO, K., MURRAY, B. P., BHADRESA, S., CROSBIE, S. J., BOOBIS, A. R. and DAVIES, D. S., 1996, Heterocyclic amines: evaluation of their role in diet associated human cancer. British Journal of Clinical Pharmacology, 42, 91–98.
   Google Scholar
• GRAHAM-LORENCE, S. E. and PETERSON, J. A., 1996, Structural alignments of P450s and extrapolations to the unknown. Methods in Enzymology, 272, 315–326.
   Google Scholar
• GRAVES, P. E., ELHAG, G. A., CIACCIO, P. J., BOURQUE, D. P. and HALPERT, J. R., 1990, cDNA and deduced amino acid sequences of a dog hepatic cytochrome P450IIB responsible for the metabolism of 2,2',4,4',5,5'-hexachlorobiphenyl. Archives of Biochemistry and Biophysics, 281, 106–115.
   PubMed Web of Science ®Google Scholar
• IWATA, M., TAKAYAMA, K., HISAMICHI, H., KUBOTA, H., KAWANO, N., AOKI, M. and IsomuRA, Y., 1998, Synthetic studies on selective type IV phosphodiesterase (PDEIV) inhibitors. III. In 216th American Chemical Society National Meeting Book of Abstracts Part 2 Medical Chemistry Division 47 (ACS).
   Google Scholar
• KAGIMOTO, M., HEIM, M., KAGIMOTO, K., ZEUGIN, T. and MEYER, U. A., 1990, Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes. Journal of Biological Chemistry, 265, 17209–17214.
   PubMed Web of Science ®Google Scholar
• LANKFORD, S. M., BAI, S. A. and GOLDSTEIN, J. A., 2000, Cloning of canine cytochrome P450 2E1 cDNA: Identification and characterization of two variant alleles. Drug Metabolism and Disposition, 28, 981–986.
   PubMed Web of Science ®Google Scholar
• MISE, M., YADERA, S., MATSUDA, M., HASHIZUME, T., MATSUMOTO, S., TERAUCHI, Y. and FUJII, T., 2004, Polymorphic expression of CYP1A2 leading to interindividual variability in metabolism of a novel benzodiazepine receptor partial inverse agonist in dogs. Drug Metabolism and Disposition, 32, 240–245.
   PubMed Web of Science ®Google Scholar
• MURAYAMA, N., SOYAMA, A., SAITO, Y., NAKAJIMA, Y., KOMAMURA, K., UENO, K., KAMAKURA, S., KITAKAZE, M., KIMURA, H., GOTO, Y., SAITOH, O., KATOH, M., OHNUMA, T., KAWAI, M., SUGAI, K., OHTSUKI, T., SUZUKI, C., MINAMI, N., OZAWA, S. and SAWADA, J., 2004, Six novel nonsynonymous CYP1A2 gene polymorphisms: catalytic activities of the naturally occurring variant enzymes. Journal of Pharmacology and Experimental Therapeutics, 308, 300–306.
   PubMed Web of Science ®Google Scholar
• NAKAJIMA, M., YOKOI, T., MIZUTANI, M., KINOSHITA, M., FUNAYAMA, M. and KAMATAKI, T., 1999, Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. Journal of Biochemistry, 125, 803–808.
   PubMed Web of Science ®Google Scholar
• NEBERT, D. W., 2000, Suggestions for the nomenclature of human alleles: relevance to ecogenetics, pharmacogenetics and molecular epidemiology. Pharmacogenetics, 10, 279–290.
   PubMedGoogle Scholar
• NELSON, D. R., KOYMANS, L., KAMATAKI, T., STEGEMAN, J. J., FEYEREISEN, R., WAXMAN, D. J., WATERMAN, M. R., GOTOH, O., COON, M. J., ESTABROOK, R. W., GUNSALUS, I. C. and NEBERT, D. W., 1996, P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6, 1–42.
   PubMedGoogle Scholar
• PAULSON, S. K., ENGEL, L., REITZ, B., BOLTEN, S., BURTON, E. G., MAZIASZ, T. J., YAN, B. and SCHOENHARD, G. L., 1999, Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor, celecoxib. Drug Metabolism and Disposition, 27, 1133–1142.
   PubMed Web of Science ®Google Scholar
• PELKONEN, O., MAENPAA, J., TAAVITSAINEN, P., RAUTIO, A. and RAUNIO, H., 1998, Inhibition and induction of human cytochrome P450 (CYP) enzymes. Xenobiotica, 28, 1203–1253.
   PubMed Web of Science ®Google Scholar
• SAKAMOTO, K., KIRITA, S., BABA, T., NAKAMURA, Y., YAMAZOE, Y., KATO, R., TAKANAKA, A. and MATSUBARA, T., 1995, a new cytochrome P450 form belonging to the CYP2D in dog liver microsomes: purification, cDNA cloning, and enzyme characterization. Archives of Biochemistry and Biophysics, 319, 372–382.
   PubMed Web of Science ®Google Scholar
• SALAVAGGIONE, O. E., KIDD, L., PRONDZINSKI, J. L., SZUMLANSKI, C. L., PANKRATZ, V. S., WANG, L., TREPANIER, L. and WEINSHILBOUM, R. M., 2002, Canine red blood cell thiopurine S-methyltransferase: companion animal pharmacogenetics. Pharmacogenetics, 12, 713–724.
   PubMedGoogle Scholar
• SHOU, M., NORCROSS, R., SANDIG, G., Lu, P., Li, Y., LIN, Y., MEI, Q., RODRIGUES, A. D. and RUSHMORE, T. H., 2003, Substrate specificity and kinetic properties of seven heterologously expressed dog cytochromes p450. Drug Metabolism and Disposition, 31, 1161–1169.
   PubMed Web of Science ®Google Scholar
• SULLIVAN-KLOSE, T. H., GHANAYEM, B. I., BELL, D. A., ZHANG, Z. Y., KAMINSKY, L. S., SHENFIELD, G. M., MINERS, J. O., BIRKETT, D. J. and GOLDSTEIN, J. A., 1996, The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism. Pharmacogenetics, 6, 341–349.
   Google Scholar
• TENMIZU, D., FUKUNAGA, Y., NOGUCHI, K. and KAMIMURA, H., 2004, Simultaneous determination of YM-64227, a phosphodiesterase type 4 inhibitor, and its five metabolites in dog plasma by high-performance liquid chromatography with fluorescence detection. Biomedical Chromatog-raphy (in press).
   Google Scholar
• TIRONA, R. G., LEAKE, B. F., MERINO, G. and Kim, R. B., 2001, Polymorphisms in OATP-C. Identification of multiple allelic variants associated with altered transport activity among European- and African-Americans. Journal of Biological Chemistry, 276, 35669–35675.
   PubMed Web of Science ®Google Scholar
• UCHIDA, T., KOMORI, M., KITADA, M. and KAMATAKI, T., 1990, Isolation of cDNAs coding for three different forms of liver microsomal cytochrome P-450 from polychlorinated biphenyl-treated beagle dogs. Molecular Pharmacology, 38, 644–651.
   PubMed Web of Science ®Google Scholar